MedeAnalytics Renews Partnership with Blue Cross & Blue Shield of Rhode Island to Enhance Analytics Insights and Reporting
MedeAnalytics, a healthcare enterprise analytics software-as-a-service (SaaS) provider, announced the renewal of its partnership with Blue Cross & Blue Shield of Rhode Island (BCBSRI). The three-year agreement expands the partnership’s previous work to provide insightful analytics for healthcare cost control and robust, comprehensive employer reporting, by adding Stop Loss reporting to quickly and accurately identify high cost/risk members with trigger diagnoses.
“We’re very pleased to continue our important work with Blue Cross & Blue Shield of Rhode Island,” said MedeAnalytics’ chief executive officer, Paul Kaiser. “Enhancing their insight into member health and early warning for more effective heath programs is absolutely consistent with BCBSRI’s history of innovation and quality. We’re honored that BCBSRI has chosen to renew our relationship.”
Stop Loss reporting supports the management of high-cost claimants, eliminates manual processing with automated reporting, and helps ensure data security standards. With the addition of Stop Loss reporting to MedeAnalytics’ Healthcare Economics and Employer Reporting solutions, health plans can access a “single source of truth” for cost control and health program analytics.
Recommended AI News: Belgium Hospital Orders Enterprise Imaging Solution From Sectra
“Accessible and accurate insights are critical to our health management programs,” said Amarnath Gurivireddygari, BCBSRI’s chief data analytics officer. “Controlling costs and managing high-cost claims is important, but the health of our members is paramount. The effectiveness of our health programs depends on readily available data insights that allow us to act quickly and get members the care and resources they need.”